Corbus Pharmaceuticals Holdings Inc (CRBP)
39.79
+0.97
(+2.50%)
USD |
NASDAQ |
May 07, 16:00
38.01
-1.78
(-4.47%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Market Cap: 418.08M for May 7, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 407.89M |
| May 03, 2024 | 407.36M |
| May 02, 2024 | 401.38M |
| May 01, 2024 | 391.39M |
| April 30, 2024 | 389.19M |
| April 29, 2024 | 374.48M |
| April 26, 2024 | 359.87M |
| April 25, 2024 | 351.99M |
| April 24, 2024 | 373.43M |
| April 23, 2024 | 396.54M |
| April 22, 2024 | 396.12M |
| April 19, 2024 | 412.30M |
| April 18, 2024 | 383.83M |
| April 17, 2024 | 390.45M |
| April 16, 2024 | 432.06M |
| April 15, 2024 | 448.87M |
| April 12, 2024 | 429.22M |
| April 11, 2024 | 420.29M |
| April 10, 2024 | 400.85M |
| April 09, 2024 | 393.70M |
| April 08, 2024 | 421.97M |
| April 05, 2024 | 419.97M |
| April 04, 2024 | 409.47M |
| April 03, 2024 | 404.53M |
| April 02, 2024 | 393.60M |
| Date | Value |
|---|---|
| April 01, 2024 | 399.17M |
| March 28, 2024 | 412.30M |
| March 27, 2024 | 373.74M |
| March 26, 2024 | 379.84M |
| March 25, 2024 | 374.37M |
| March 22, 2024 | 367.12M |
| March 21, 2024 | 400.31M |
| March 20, 2024 | 411.01M |
| March 19, 2024 | 448.68M |
| March 18, 2024 | 436.72M |
| March 15, 2024 | 458.34M |
| March 14, 2024 | 473.55M |
| March 13, 2024 | 494.02M |
| March 12, 2024 | 467.78M |
| March 11, 2024 | 401.68M |
| March 08, 2024 | 471.46M |
| March 07, 2024 | 416.78M |
| March 06, 2024 | 347.11M |
| March 05, 2024 | 357.65M |
| March 04, 2024 | 375.43M |
| March 01, 2024 | 361.79M |
| February 29, 2024 | 319.41M |
| February 28, 2024 | 289.43M |
| February 27, 2024 | 269.48M |
| February 26, 2024 | 294.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.927M
Minimum
Mar 10 2023
766.45M
Maximum
Sep 02 2020
191.83M
Average
127.74M
Median
Sep 17 2021
Market Cap Benchmarks
| AIM ImmunoTech Inc | 21.23M |
| Perspective Therapeutics Inc | 1.077B |
| Protalix BioTherapeutics Inc | 82.91M |
| Electromed Inc | 150.59M |
| Armata Pharmaceuticals Inc | 104.83M |
Market Cap Related Metrics
| PS Ratio | 111.80 |
| Price | 39.79 |
| Earnings Yield | -26.01% |